MedPath

Gianvi

Gianvi (drospirenone and ethinyl estradiol) Tablets

Approved
Approval ID

b61cdce5-9fb5-4901-a768-4282a684db3f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 3, 2010

Manufacturers
FDA

MedVantx, Inc.

DUNS: 806427725

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Drospirenone and ethinyl estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66116-470
Application NumberNDA021676
Product Classification
M
Marketing Category
C73594
G
Generic Name
Drospirenone and ethinyl estradiol
Product Specifications
Effective DateJuly 20, 2009
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Gianvi - FDA Drug Approval Details